Macromolecular intravenous contrast agent for MR lymphography: Characterization and efficacy studies

Radiology

Volumn 198, Issue 2, 1996, Pages 365-370

  Harika, Liliane ^a   Weissleder, Ralph ^a   Poss, Kirt ^a   Papisov, Mikhail I ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Computed tomography (CT), contrast media; Gadolinium; Indium, radioactive; Lymphatic system, MR; Lymphatic system, neoplasms; Lymphatic system, radionuclide studies; Magnetic resonance (MR), contrast enhancement

Indexed keywords

GADOLINIUM PENTETATE; PENTETIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTRAST RADIOGRAPHY; CONTROLLED STUDY; DRUG EFFICACY; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; LYMPHOGRAPHY; MACROMOLECULE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; RAT;

EID: 0030026626     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.198.2.8596833     Document Type: Article

References (25)

1. Castellino RA, Marglin SI. Imaging of abdominal and pelvic lymph nodes: lymphography or computed tomography? Invest Radiol 1982, 17:433-443.
2. Glazer GM, Orringer MB, TL Chenevert, et al. Mediastinal lymph nodes: relaxation time/pathologic correlation and implications in staging of lung cancer with MR imaging. Radiology 1988; 168:429-431.
3. Coleman RL, Burke TW, Morris M, et al. Intraoperative radiographs to confirm the adequacy of lymph node resection in patients with suspicious lymphangiograms. Gynecol Oncol 1993; 51:362-367.
4. American Cancer Society. Cancer facts and figures, 1994. Atlanta, Ga: American Cancer Society, 1994; 1-24.
5. Herrera-Ornales L, Justiniano J, Castillo N, Petrelli NJ, Stule JP. Metastases in small lymph nodes from colon cancer. Arch Surg 1987; 122:1253-1256.
6. Lee JKT, Stanley RJ, Sagel SS, McClennan BL Accuracy of CT in detecting intraabdominal and pelvic lymph node metastases from pelvic cancers. AJR 1978; 131:675-679.
7. Abrams HL, Spiro R, Goldstein N Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 1950; 3:74-85.
8. Baas PC, Schraffordt Koops H, Hoekstra HJ, Van Bruggen JJ, Van der Weele LT, Oldhoff J. Groin dissection in the treatment of lower-extremity melanoma: short term and long term morbidity. Arch Surg 1992; 127:281-286.
9. Simon MS, Cody RL. Cellulitis after axillary lymph node dissection for carcinoma of the breast. Am J Med 1992; 93:534-538.
10. Castellino RA, Hoppe RT, Blank N, et al Computed tomography, lymphography, and staging laparotomy: correlations in initial staging of Hodgkins disease. AJR 1984; 143:37-42.
11. Castellino RA. Hodgkin disease: practical concepts for the diagnostic radiologist. Radiology 1986; 159:305-310.
12. Weissleder R, Elizondo G, Wittenberg J, Rabito C, Bengele HH, Josephson L. Ultrasmall superparamagnetic iron oxide (USPIO): characterization of a new class of contrast agents for MR imaging. Radiology 1990; 175:489-493.
13. Weissleder R, Elizondo G, Wittenberg J, Lee AS, Josephson L, Brady TJ. Ultrasmall superparamagnetic iron oxide (USPIO): an intravenous contrast agent for assessing lymph nodes with MR imaging. Radiology 1990; 175:494-498.
14. Poss K, Bogdanova A, Weissleder R, Brady TJ, Papisov MI. Cytotoxicity of doxorubicin covalently linked with the backbone of lymphotropic graft copolymer (abstr). In: Book of abstracts of the Seventh International Symposium on Recent Advances in Drug Delivery Systems Salt Lake City, Utah: University of Utah Press, 1995; 173-174.
15. Papisov MI, Weissleder R, Schaffer B, Bogdanov AA Jr, Brady TJ. Intravenous carriers for drug delivery to lymph nodes (abstr). In: Book of abstracts of the Sixth International Symposium on Recent Advances in Drug Delivery Systems. Salt Lake City, Utah: University of Utah Press, 1993; 137.
16. Papisov MI, Weissleder R, Schaffer B, et al. Lymphotropic contrast agents: in vivo transfer processes (abstr). In. Book of abstracts: Society of Magnetic Resonance in Medicine 1993. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1993, 499.
17. Harika L, Weissleder R, Poss K, Zimmer C, Papisov MI, Brady TJ. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA PGM. Magn Reson Med 1994; 33:88-92.
18. Croll M, Brady L, Dadparvar S. Implications of lymphoscintigraphy in oncologic practice: principles and differences vis-a-vis other imaging modalities. Semin Nucl Med 1983; 13:4-8.
19. Ege G, Cummings B. Interstitial radiocolloid iliopelvic lymphoscintigraphy: technique, anatomy, and clinical application. Int J Radiat Oncol Biol Phys 1980; 6:1483-1490.
20. Slater G, Mayo-Smith WW, Sharma P, Schnall M, Rifkin MD. Ultrasmall super-paramagnetic iron oxide particles in pelvic lymph nodes in primary pelvic carcinoma: preliminary observations (abstr). Radiology 1994; 193(P):315.
21. Papisov M, Schaffer B, Weissleder R, et al. Colloid contrast agents protected by extended dextran layer (abstr). In: Book of abstracts Society for Magnetic Resonance in Medicine 1992. Berkeley, Calif: Society for Magnetic Resonance in Medicine, 1992; 1403.
22. Papisov MI, Weissleder R, Brady TJ. Diagnostic targeting of lymph nodes with polymeric imaging agents. In: Torchillin VP, ed. Targeted delivery of imaging agents. Boca Raton, Fla: CRC, 1995; 385-401.
23. Doherty NS, Beaver TH. Comparison of the anaphylactoid response induced in rats by castanospermine and dextran. Int Arch Allergy Appl Immunol 1990; 93:19-25.
24. Weissleder R, Heautot JF, Scharfer BK, et al. MR lymphography: study of a high-efficiency lymphotropic agent. Radiology 1994; 191:225-230.
25. Lee AS, Weissleder R, Wittenberg J, Brady TJ. Lymph nodes: microstructural anatomy at MR imaging. Radiology 1991, 178:519-522.